IncFact
Company Profiles: Revenue, Growth, Competition

REPLIGEN Revenue, Growth & Competitor Profile

Last updated:

Company Awards

 
Public Company
public company
Fast Growing
Fastest Growing
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Repligen

Access the complete profile.

Repligen Fast Facts

Revenue$100 - $500 million    See Exact Annual Revenue
Employees100 - 500Exact Company Size
Primary Industry325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes3253 Pesticide, Fertilizer & Agricultural Chemical Manufacturing
32541
325414 Biological Product Manufacturing
5417 Scientific Research & Development Services
Address41 Seyon St Bldg 1 Ste 100
Waltham, MA 02453

www.repligen.com


Repligen's annual revenues are $100-$500 million (see exact revenue data) and has 100-500 employees. It is classified as operating in the Medicinal & Botanical Manufacturing industry.


Repligen's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Repligen is a publicly traded company on NMS using the ticker symbol RGEN. Detailed information on company financials and operating reports can be found here: NMS: RGEN



Repligen Annual Revenue and Growth Rate

Repligen Revenue Est.
($ Million)
Growth Rate (%)# Employees
2018 Details in Premium Report
2017
2016
2015
2014
2013


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Repligen's revenues are gauged from an analysis of company filings.



Investor Activity

Repligen has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
June 13, 2019 1 100%$48 MM
Complete list of funding rounds and total amounts in the Company Report




Trademark Applications

Trademark applications show the products and services that Repligen is developing and marketing. Repligen's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
SPECTRAFLO
Laboratory apparatus, namely, molecular separation, purification and dialysis systems and their structural components including dialysis tanks, systems, membranes and tubing
04/18/2019
NGL-IMPACTA
Affinity ligands for biological purification purposes
07/02/2018
NGL-IMPACT
Affinity ligands for biological purification purposes
06/26/2018

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Repligen grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Repligen is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Medicinal & Botanical Manufacturing

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Repligen's Largest Competitors

A competitive analysis shows these companies are in the same general field as Repligen, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
TMUNITY THERAPEUTICSPhiladelphia, PA100 
PANACEA BIOMATXResearch Triangle Park, NC52 




Nearby Competitors

These companies are similar in business line and location to Repligen. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
BIOGEN U.S.Weston, MA100 
SHIRE HOLDINGS US AGLexington, MA73 
CUBIST PHARMACEUTICALSLexington, MA7 
BIOVERATIVWaltham, MA7 
AMAG PHARMACEUTICALSWaltham, MA4 
REPLIGENWaltham, MA1 




Future Competition: Repligen's Fastest Growing Competitors

These companies are in the same general field as Repligen and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Repligen Competitors